Dianeal PD-2
 Dianeal with Dextrose

drug-information.ru

|Dianeal PD-2 Dianeal with Dextrose

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Dianeal PD-2


Generic Name: sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
Dosage Form: Injection, solution

Dianeal PD-2 Description

Dianeal® PD-2 peritoneal dialysis solutions are sterile, nonpyrogenic solutions in UltraBag™ containers for intraperitoneal administration only. They contain no bacteriostatic or antimicrobial agents.

UltraBag™ containers are designed with an integrated “Y” set and drain container for infusion and drainage of Dianeal® PD-2 when disconnection of the “Y” set from the transfer set during dwell is desired.

Composition, calculated osmolarity, pH, and ionic concentrations are shown in the following table.

Composition/100mL OSMOLARITY (mOsmol/L) (calc) pH Ionic Concentration (mEq/L) How Supplied
Dextrose, Hydrous, USP Sodium Chloride, USP (NaCl) Sodium Lactate (C3H5NaO3) Calcium Chloride, USP (CaCl2·2H2O) Magnesium Chloride, USP (MgCl2·6H2O) Sodium Calcium Magnesium Chloride Lacate Fill Volume (mL) Container Size (mL) Code NDC
Dianeal®PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 1.5 g 538 mg 448 mg 25.7 mg 5.08 mg 346 5.2
(4.0 & to 6.5)
132 3.5 0.5 96 40 1500
2000
2500
3000
2000
2000
3000
5000
5B9865
5B9866
5B9868
5B9857
0941-0426-51
0941-0426-52
0941-0426-53
0941-0426-55
Dianeal®PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose 2.5 g 538 mg 448 mg 25.7 mg 5.08 mg 396 5.2
(4.0 to 6.5)
132 3.5 0.5 96 40 1500
2000
2500
3000
2000
2000
3000
5000
5B9875
5B9876
5B9878
5B9858
0941-0427-51
0941-0427-52
0941-0427-53
0941-0427-55
Dianeal®PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose 4.25 g 538 mg 448 mg 25.7 mg 5.08 mg 485 5.2
(4.0 to 6.5)
132 3.5 0.5 96 40 1500
2000
2500
3000
2000
2000
3000
5000
5B9895
5B9896
5B9898
5B9859
0941-0429-51
0941-0429-52
0941-0429-53
0941-0429-55

The plastic container tubing set is fabricated from polyvinyl chloride (PL 146® Plastic). Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. The amount of water that can permeate from inside the solution container into the overpouch is insufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials.

Dianeal PD-2 - Clinical Pharmacology

Peritoneal dialysis is a procedure for removing toxic substances and metabolites normally excreted by the kidneys, and for aiding in the regulation of fluid and electrolyte balance.

The procedure is accomplished by instilling peritoneal dialysis fluid through a conduit into the peritoneal cavity. Toxic substances and metabolites, present in high concentration in the blood, cross the peritoneal membrane into the dialyzing fluid. Dextrose in the dialyzing fluid is used to produce a solution hyperosmolar to the plasma, creating an osmotic gradient which facilitates fluid removal from the patient’s plasma into the peritoneal cavity. After a period of time, (dwell time), the fluid is drained by gravity from the cavity.

The solution does not contain potassium. In situations in which there is a normal serum potassium level or hypokalemia, the addition of potassium chloride (up to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia. Addition of potassium chloride should be made after careful evaluation of serum and total body potassium and only under the direction of a physician.

Clinical studies have demonstrated the use of this solution resulted in significant increases in serum CO2 and decreases in serum magnesium levels. The decrease in magnesium levels did not cause clinically significant hypomagnesemia.

Indications and Usage for Dianeal PD-2

Dianeal® PD-2 peritoneal dialysis solutions in UltraBag™ containers are indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis when nondialytic medical therapy is judged to be inadequate.

Contraindications

None known.

Warnings

Not for Intravenous Injection.

Use aseptic technique. Contamination of Luer lock connector may result in peritonitis.

An improper clamping sequence may result in infusion of air into the peritoneum.

Peritoneal dialysis should be done with great care, if at all, in patients with a number of conditions, including disruption of the peritoneal membrane or diaphragm by surgery or trauma, extensive adhesions, bowel distention, undiagnosed abdominal disease, abdominal wall infection, hernias or burns, fecal fistula or colostomy, tense ascites, obesity, large polycystic kidneys, recent aortic graft replacement, lactic acidosis, and severe pulmonary disease. When assessing peritoneal dialysis as the mode of therapy in such extreme situations, the benefits to the patient must be weighed against the possible complications.

An accurate fluid balance record must be kept and the weight of the patient carefully monitored to avoid over or under hydration with severe consequences, including congestive heart failure, volume depletion, and shock.

Excessive use of Dianeal® PD-2 peritoneal dialysis solution with 4.25% dextrose during a peritoneal dialysis treatment can result in significant removal of water from the patient.

Stable patients undergoing maintenance peritoneal dialysis should have routine periodic evaluation of blood chemistries and hematologic factors, as well as other indicators of patient status.

If the resealable rubber plug on the medication port is missing or partially removed, do not use product.

After removing overpouch, check for minute leaks by squeezing container firmly. If leaks are found, discard the solution because the sterility may be impaired.

After the pull ring has been removed from the outlet, check for broken connector frangible seal as evidenced by continuous fluid flow from port. A few drops of solution within the connector or protector cap may be present. If a continuous stream or droplets of fluid are noted, discard solution because sterility may be impaired.

During solution drainage, fibrin strands may be observed in the solution and may become attached to the connector frangible closure. In occasional instances, partial or complete obstruction of draining may occur. Manipulation of the connector frangible closure in the tubing may free the fibrin obstruction.

Precautions

General

Do not administer unless solution is clear.

Aseptic technique must be used throughout the procedure and at its termination in order to reduce the possibility of infection.

Significant losses of protein, amino acids and water soluble vitamins may occur during peritoneal dialysis. Replacement therapy should be provided as necessary.

When prescribing the solution to be used for an individual patient, consideration should be given to the potential interaction between the dialysis treatment and therapy directed at other existing illnesses. For example, rapid potassium removal may create arrhythmias in cardiac patients using digitalis or similar drugs; digitalis toxicity may be masked by elevated potassium or magnesium, or by hypocalcemia. Correction of electrolytes by dialysis may precipitate signs and symptoms of digitalis excess. Conversely, toxicity may occur at suboptimal dosages of digitalis if potassium is low or calcium high. Azotemic diabetics require careful monitoring of insulin requirements during and following dialysis with dextrose containing solutions.

Laboratory Tests

Serum electrolytes, magnesium, bicarbonate levels and fluid balance should be periodically monitored.

Carcinogenesis and Mutagenesis and Impairment of Fertility

Long term animal studies with Dianeal® PD-2 peritoneal dialysis solution have not been performed to evaluate the carcinogenic potential, mutagenic potential or effect on fertility.

Pregnancy

Teratogenic Effects

Pregnancy Category C

Animal reproduction studies have not been conducted with Dianeal® PD-2 peritoneal dialysis solution. It is also not known whether Dianeal® PD-2 peritoneal dialysis solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dianeal® PD-2 peritoneal dialysis solution should be given to a pregnant woman only if clearly needed.

Nursing Mothers

Caution should be exercised when Dianeal® PD-2 peritoneal dialysis solution is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in children have not been established.

Adverse Reactions

Adverse reactions to peritoneal dialysis include mechanical and solution related problems as well as the results of contamination of equipment or improper technique in catheter placement. Abdominal pain, bleeding, peritonitis, subcutaneous infection around the peritoneal catheter, catheter site infection, catheter blockage, difficulty in fluid removal, and ileus are among the complications of the procedure. Solution related adverse reactions may include peritonitis, electrolyte and fluid imbalances, hypovolemia, hypervolemia, hypotension, hypertension, disequilibrium syndrome, allergic symptoms, and muscle cramping.

Dianeal PD-2 Dosage and Administration

Dianeal® PD-2 solutions are intended for intraperitoneal administration only.

It is recommended that adult patients being placed on continuous ambulatory peritoneal dialysis should be appropriately trained in a program which is under the supervision of a physician. Training materials are available from Baxter Healthcare Corporation, Deerfield, IL, 60015 USA to facilitate this training.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

The frequency of treatment, formulation, exchange volume, duration of dwell, and length of dialysis should be selected by the physician responsible for and supervising the treatment of the individual patient.

To avoid the risk of severe dehydration and hypovolemia and to minimize the loss of protein, it is advisable to select the peritoneal dialysis solution with the lowest level of osmolarity consistent with the fluid removal requirements for that exchange.

Heating the dialysis solution to 37°C (98.6°F) may decrease discomfort.

Additives may be incompatible. Do not store solution containing additives.

Two liters of dialysis solution are instilled into the peritoneal cavity of adults and the peritoneal access device is then clamped. The solution remains in the cavity for dwell times of 4 to 8 hours during the day and 8 to 12 hours overnight. At the conclusion of each dwell period, the access device is opened, the solution drained and fresh solution instilled. The procedure is repeated 3 to 5 times per day, 6 to 7 days per week. Solution exchange frequency should be individualized for adequate biochemical and fluid volume control. The majority of exchanges will utilize 1.5% or 2.5% dextrose containing peritoneal dialysis solutions, with 4.25% dextrose containing solutions being used when extra fluid removal is required. Patient weight is used as the indicator of the need for fluid removal.

DIRECTIONS FOR USE

Use aseptic technique.

For complete system preparation, see directions accompanying ancillary equipment.

Preparation for Administration

1. Gather supplies.

2. Tear the container overpouch firmly down the side from top slit and remove. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity should diminish gradually.

3. Place container on work surface.

4. Uncoil tubing.

5. Inspect the patient connector to ensure the pull ring is attached. Do not use if pull ring is not attached to the connector.

6. Inspect tubing and drain container for presence of solution. If solution is noted, discard units. NOTE: Small water droplets are acceptable.

7. Squeeze container to check for leaks and broken solution frangible. Note solution flow past the frangible. Discard if container or solution frangible leaks, because sterility may be impaired.

If Supplemental Medication is Prescribed

1. Inspect container to ensure resealable rubber medication port is in place. Discard if rubber injection port is not attached to container port.

2. Put on a mask.

3. Prepare medication port according to aseptic technique.

4. Using a syringe with a 1 inch long, 19 to 25 gauge needle, puncture resealable medication port and inject medication.

5. Position container with medication port facing upward. Squeeze and tap medication port to empty solution. Mix solution by vigorously agitating container.

Administration

1. Put on mask and wash hands.

2. Insure patient transfer set is closed.

3. Break connector frangible (blue) by grasping the tubing above the top of the frangible and pulling forward and backward until the frangible separates from base. See Figures 1 and 2.

4. Remove pull ring from the patient connector.

5. Remove disconnect cap from patient transfer set. Immediately attach patient transfer set connector to the patient connector by twisting the connector until firmly secured.

6. Clamp solution line.

7. Break solution frangible (green) by grasping the tubing above the top of the frangible and pulling forward and backward until the frangible separates. See Figures 3 and 4.

8. Hang the new solution container.

9. Place the drainage container below the level of the peritoneum.

10. Open transfer set clamp to drain solution from peritoneum. Warning: During solution drainage, fibrin strands may become attached to the connector frangible closure. Manipulation of the connector frangible closure in the tubing may free any fibrin obstruction that occurs.

11. Close transfer set line clamp after drainage is complete.

12. Open solution line clamp and allow the new solution to flow into the drainage container for 5 seconds to prime line.

13. Clamp drain line.

14. Open transfer set clamp and allow the solution to flow into the peritoneum.

15. Close transfer set clamp when infusion is complete.

16. Prepare a new disconnect cap following the directions accompanying the cap.

17. Disconnect the patient transfer set connection from the UltraBag™ and attach a new disconnect cap to the transfer set.

Administration Procedure for the UltraBag™ Container Exchange

(The Steps Refer to the Corresponding Administration Steps)

How is Dianeal PD-2 Supplied

Dianeal® PD-2 peritoneal dialysis solutions in UltraBag™ containers are available in nominal size flexible containers as shown in the table in the DESCRIPTION section.

All Dianeal® PD-2 peritoneal dialysis solutions have overfills which are declared on container labeling.

Freezing of solution may occur at temperatures below 0°C (32°F). Allow to thaw naturally in ambient conditions and thoroughly mix contents by shaking.

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F).

Baxter Healthcare Corporation

Deerfield, IL 60015 USA

07-19-26-994 2002/02


Dianeal PD-2 with Dextrose (sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose)
PRODUCT INFO
Product Code 0941-0426 Dosage Form INJECTION, SOLUTION
Route Of Administration INTRAPERITONEAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Dextrose Hydrous (dextrose) Active 1.5 GRAM  In 100 MILLILITER
Sodium Chloride (sodium chloride) Active 538 MILLIGRAM  In 100 MILLILITER
Sodium Lactate (sodium lactate) Active 448 MILLIGRAM  In 100 MILLILITER
Calcium Chloride (calcium chloride) Active 25.7 MILLIGRAM  In 100 MILLILITER
Magnesium Chloride (magnesium chloride) Active 5.08 MILLIGRAM  In 100 MILLILITER
Water Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0941-0426-51 1500 MILLILITER In 1 BAG None
2 0941-0426-52 2000 MILLILITER In 1 BAG None
3 0941-0426-53 2500 MILLILITER In 1 BAG None
4 0941-0426-55 3000 MILLILITER In 1 BAG None

Dianeal PD-2 with Dextrose (sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose)
PRODUCT INFO
Product Code 0941-0427 Dosage Form INJECTION, SOLUTION
Route Of Administration INTRAPERITONEAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Dextrose Hydrous (dextrose) Active 2.5 GRAM  In 100 MILLILITER
Sodium Chloride (sodium chloride) Active 538 MILLIGRAM  In 100 MILLILITER
Sodium Lactate (sodium lactate) Active 448 MILLIGRAM  In 100 MILLILITER
Calcium Chloride (calcium chloride) Active 25.7 MILLIGRAM  In 100 MILLILITER
Magnesium Chloride (magnesium chloride) Active 5.08 MILLIGRAM  In 100 MILLILITER
Water Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0941-0427-51 1500 MILLILITER In 1 BAG None
2 0941-0427-52 2000 MILLILITER In 1 BAG None
3 0941-0427-53 2500 MILLILITER In 1 BAG None
4 0941-0427-55 3000 MILLILITER In 1 BAG None

Dianeal PD-2 with Dextrose (sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose)
PRODUCT INFO
Product Code 0941-0429 Dosage Form INJECTION, SOLUTION
Route Of Administration INTRAPERITONEAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Dextrose Hydrous (dextrose) Active 4.25 GRAM  In 100 MILLILITER
Sodium Chloride (sodium chloride) Active 538 MILLIGRAM  In 100 MILLILITER
Sodium Lactate (sodium lactate) Active 448 MILLIGRAM  In 100 MILLILITER
Calcium Chloride (calcium chloride) Active 25.7 MILLIGRAM  In 100 MILLILITER
Magnesium Chloride (magnesium chloride) Active 5.08 MILLIGRAM  In 100 MILLILITER
Water Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0941-0429-51 1500 MILLILITER In 1 BAG None
2 0941-0429-52 2000 MILLILITER In 1 BAG None
3 0941-0429-53 2500 MILLILITER In 1 BAG None
4 0941-0429-55 3000 MILLILITER In 1 BAG None

Revised: 09/2006





Where can I get more information about Dianeal PD-2 Dianeal with Dextrose ? We recommend to use www.Drugs.com

Typical mistypes for Dianeal PD-2 Dianeal with Dextrose
sianeal pd-2 dianeal with dextrose, xianeal pd-2 dianeal with dextrose, cianeal pd-2 dianeal with dextrose, fianeal pd-2 dianeal with dextrose, rianeal pd-2 dianeal with dextrose, eianeal pd-2 dianeal with dextrose, duaneal pd-2 dianeal with dextrose, djaneal pd-2 dianeal with dextrose, dkaneal pd-2 dianeal with dextrose, doaneal pd-2 dianeal with dextrose, d9aneal pd-2 dianeal with dextrose, d8aneal pd-2 dianeal with dextrose, dizneal pd-2 dianeal with dextrose, disneal pd-2 dianeal with dextrose, diwneal pd-2 dianeal with dextrose, diqneal pd-2 dianeal with dextrose, diabeal pd-2 dianeal with dextrose, diameal pd-2 dianeal with dextrose, diajeal pd-2 dianeal with dextrose, diaheal pd-2 dianeal with dextrose, dianwal pd-2 dianeal with dextrose, diansal pd-2 dianeal with dextrose, diandal pd-2 dianeal with dextrose, dianral pd-2 dianeal with dextrose, dian4al pd-2 dianeal with dextrose, dian3al pd-2 dianeal with dextrose, dianezl pd-2 dianeal with dextrose, dianesl pd-2 dianeal with dextrose, dianewl pd-2 dianeal with dextrose, dianeql pd-2 dianeal with dextrose, dianeak pd-2 dianeal with dextrose, dianeap pd-2 dianeal with dextrose, dianeao pd-2 dianeal with dextrose, dianeal od-2 dianeal with dextrose, dianeal ld-2 dianeal with dextrose, dianeal -d-2 dianeal with dextrose, dianeal 0d-2 dianeal with dextrose, dianeal ps-2 dianeal with dextrose, dianeal px-2 dianeal with dextrose, dianeal pc-2 dianeal with dextrose, dianeal pf-2 dianeal with dextrose, dianeal pr-2 dianeal with dextrose, dianeal pe-2 dianeal with dextrose, dianeal pd02 dianeal with dextrose, dianeal pdp2 dianeal with dextrose, dianeal pd-1 dianeal with dextrose, dianeal pd-q dianeal with dextrose, dianeal pd-w dianeal with dextrose, dianeal pd-3 dianeal with dextrose, dianeal pd-2 sianeal with dextrose, dianeal pd-2 xianeal with dextrose, dianeal pd-2 cianeal with dextrose, dianeal pd-2 fianeal with dextrose, dianeal pd-2 rianeal with dextrose, dianeal pd-2 eianeal with dextrose, dianeal pd-2 duaneal with dextrose, dianeal pd-2 djaneal with dextrose, dianeal pd-2 dkaneal with dextrose, dianeal pd-2 doaneal with dextrose, dianeal pd-2 d9aneal with dextrose, dianeal pd-2 d8aneal with dextrose, dianeal pd-2 dizneal with dextrose, dianeal pd-2 disneal with dextrose, dianeal pd-2 diwneal with dextrose, dianeal pd-2 diqneal with dextrose, dianeal pd-2 diabeal with dextrose, dianeal pd-2 diameal with dextrose, dianeal pd-2 diajeal with dextrose, dianeal pd-2 diaheal with dextrose, dianeal pd-2 dianwal with dextrose, dianeal pd-2 diansal with dextrose, dianeal pd-2 diandal with dextrose, dianeal pd-2 dianral with dextrose, dianeal pd-2 dian4al with dextrose, dianeal pd-2 dian3al with dextrose, dianeal pd-2 dianezl with dextrose, dianeal pd-2 dianesl with dextrose, dianeal pd-2 dianewl with dextrose, dianeal pd-2 dianeql with dextrose, dianeal pd-2 dianeak with dextrose, dianeal pd-2 dianeap with dextrose, dianeal pd-2 dianeao with dextrose, dianeal pd-2 dianeal qith dextrose, dianeal pd-2 dianeal aith dextrose, dianeal pd-2 dianeal sith dextrose, dianeal pd-2 dianeal eith dextrose, dianeal pd-2 dianeal 3ith dextrose, dianeal pd-2 dianeal 2ith dextrose, dianeal pd-2 dianeal wuth dextrose, dianeal pd-2 dianeal wjth dextrose, dianeal pd-2 dianeal wkth dextrose, dianeal pd-2 dianeal woth dextrose, dianeal pd-2 dianeal w9th dextrose, dianeal pd-2 dianeal w8th dextrose, dianeal pd-2 dianeal wirh dextrose, dianeal pd-2 dianeal wifh dextrose, dianeal pd-2 dianeal wigh dextrose, dianeal pd-2 dianeal wiyh dextrose, dianeal pd-2 dianeal wi6h dextrose, dianeal pd-2 dianeal wi5h dextrose, dianeal pd-2 dianeal witg dextrose, dianeal pd-2 dianeal witb dextrose, dianeal pd-2 dianeal witn dextrose, dianeal pd-2 dianeal witj dextrose, dianeal pd-2 dianeal witu dextrose, dianeal pd-2 dianeal wity dextrose, dianeal pd-2 dianeal with sextrose, dianeal pd-2 dianeal with xextrose, dianeal pd-2 dianeal with cextrose, dianeal pd-2 dianeal with fextrose, dianeal pd-2 dianeal with rextrose, dianeal pd-2 dianeal with eextrose, dianeal pd-2 dianeal with dwxtrose, dianeal pd-2 dianeal with dsxtrose, dianeal pd-2 dianeal with ddxtrose, dianeal pd-2 dianeal with drxtrose, dianeal pd-2 dianeal with d4xtrose, dianeal pd-2 dianeal with d3xtrose, dianeal pd-2 dianeal with deztrose, dianeal pd-2 dianeal with dectrose, dianeal pd-2 dianeal with dedtrose, dianeal pd-2 dianeal with destrose, dianeal pd-2 dianeal with dexrrose, dianeal pd-2 dianeal with dexfrose, dianeal pd-2 dianeal with dexgrose, dianeal pd-2 dianeal with dexyrose, dianeal pd-2 dianeal with dex6rose, dianeal pd-2 dianeal with dex5rose, dianeal pd-2 dianeal with dexteose, dianeal pd-2 dianeal with dextdose, dianeal pd-2 dianeal with dextfose, dianeal pd-2 dianeal with dexttose, dianeal pd-2 dianeal with dext5ose, dianeal pd-2 dianeal with dext4ose, dianeal pd-2 dianeal with dextrise, dianeal pd-2 dianeal with dextrkse, dianeal pd-2 dianeal with dextrlse, dianeal pd-2 dianeal with dextrpse, dianeal pd-2 dianeal with dextr0se, dianeal pd-2 dianeal with dextr9se, dianeal pd-2 dianeal with dextroae, dianeal pd-2 dianeal with dextroze, dianeal pd-2 dianeal with dextroxe, dianeal pd-2 dianeal with dextrode, dianeal pd-2 dianeal with dextroee, dianeal pd-2 dianeal with dextrowe, dianeal pd-2 dianeal with dextrosw, dianeal pd-2 dianeal with dextross, dianeal pd-2 dianeal with dextrosd, dianeal pd-2 dianeal with dextrosr, dianeal pd-2 dianeal with dextros4, dianeal pd-2 dianeal with dextros3, ianeal pd-2 dianeal with dextrose, daneal pd-2 dianeal with dextrose, dineal pd-2 dianeal with dextrose, diaeal pd-2 dianeal with dextrose, dianal pd-2 dianeal with dextrose, dianel pd-2 dianeal with dextrose, dianea pd-2 dianeal with dextrose, dianealpd-2 dianeal with dextrose, dianeal d-2 dianeal with dextrose, dianeal p-2 dianeal with dextrose, dianeal pd2 dianeal with dextrose, dianeal pd- dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 ianeal with dextrose, dianeal pd-2 daneal with dextrose, dianeal pd-2 dineal with dextrose, dianeal pd-2 diaeal with dextrose, dianeal pd-2 dianal with dextrose, dianeal pd-2 dianel with dextrose, dianeal pd-2 dianea with dextrose, dianeal pd-2 dianealwith dextrose, dianeal pd-2 dianeal ith dextrose, dianeal pd-2 dianeal wth dextrose, dianeal pd-2 dianeal wih dextrose, dianeal pd-2 dianeal wit dextrose, dianeal pd-2 dianeal withdextrose, dianeal pd-2 dianeal with extrose, dianeal pd-2 dianeal with dxtrose, dianeal pd-2 dianeal with detrose, dianeal pd-2 dianeal with dexrose, dianeal pd-2 dianeal with dextose, dianeal pd-2 dianeal with dextrse, dianeal pd-2 dianeal with dextroe, dianeal pd-2 dianeal with dextros, idaneal pd-2 dianeal with dextrose, daineal pd-2 dianeal with dextrose, dinaeal pd-2 dianeal with dextrose, diaenal pd-2 dianeal with dextrose, dianael pd-2 dianeal with dextrose, dianela pd-2 dianeal with dextrose, dianea lpd-2 dianeal with dextrose, dianealp d-2 dianeal with dextrose, dianeal dp-2 dianeal with dextrose, dianeal p-d2 dianeal with dextrose, dianeal pd2- dianeal with dextrose, dianeal pd- 2 dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 d ianeal with dextrose, dianeal pd-2 idaneal with dextrose, dianeal pd-2 daineal with dextrose, dianeal pd-2 dinaeal with dextrose, dianeal pd-2 diaenal with dextrose, dianeal pd-2 dianael with dextrose, dianeal pd-2 dianela with dextrose, dianeal pd-2 dianea lwith dextrose, dianeal pd-2 dianealw ith dextrose, dianeal pd-2 dianeal iwth dextrose, dianeal pd-2 dianeal wtih dextrose, dianeal pd-2 dianeal wiht dextrose, dianeal pd-2 dianeal wit hdextrose, dianeal pd-2 dianeal withd extrose, dianeal pd-2 dianeal with edxtrose, dianeal pd-2 dianeal with dxetrose, dianeal pd-2 dianeal with detxrose, dianeal pd-2 dianeal with dexrtose, dianeal pd-2 dianeal with dextorse, dianeal pd-2 dianeal with dextrsoe, dianeal pd-2 dianeal with dextroes, ddianeal pd-2 dianeal with dextrose, diianeal pd-2 dianeal with dextrose, diaaneal pd-2 dianeal with dextrose, dianneal pd-2 dianeal with dextrose, dianeeal pd-2 dianeal with dextrose, dianeaal pd-2 dianeal with dextrose, dianeall pd-2 dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal ppd-2 dianeal with dextrose, dianeal pdd-2 dianeal with dextrose, dianeal pd--2 dianeal with dextrose, dianeal pd-22 dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 ddianeal with dextrose, dianeal pd-2 diianeal with dextrose, dianeal pd-2 diaaneal with dextrose, dianeal pd-2 dianneal with dextrose, dianeal pd-2 dianeeal with dextrose, dianeal pd-2 dianeaal with dextrose, dianeal pd-2 dianeall with dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 dianeal wwith dextrose, dianeal pd-2 dianeal wiith dextrose, dianeal pd-2 dianeal witth dextrose, dianeal pd-2 dianeal withh dextrose, dianeal pd-2 dianeal with dextrose, dianeal pd-2 dianeal with ddextrose, dianeal pd-2 dianeal with deextrose, dianeal pd-2 dianeal with dexxtrose, dianeal pd-2 dianeal with dexttrose, dianeal pd-2 dianeal with dextrrose, dianeal pd-2 dianeal with dextroose, dianeal pd-2 dianeal with dextrosse, dianeal pd-2 dianeal with dextrosee, etc.



© Copyright by drug-information.ru 2001-2019. All rights reserved